Fig. 2From: Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapyEffects of ZnONP nanocomposites on growth inhibition rate of EAC tumor cell line after 72Â h of In vitro treatment using MTT assay. (A) DOX, (B) ZnONPs, (C) ZnONPs loaded with DOX (ZnONPs/DOX). (D) ZnONPs loaded with FA (ZnONPs/FA). (E) ZnONPs loaded with DOX and FA (ZnONPs/DOX/FA)Back to article page